← Browse by Condition
Medical Condition

pregnancy high risk

Total Trials
5
Recruiting Now
5
Trial Phases
Phase 4

ClinicalMetric tracks all active clinical trials for pregnancy high risk sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — pregnancy high risk Clinical Trials

How many clinical trials are currently recruiting for pregnancy high risk?
ClinicalMetric currently tracks 5 actively recruiting clinical trials for pregnancy high risk, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 5. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for pregnancy high risk?
pregnancy high risk research spans Phase 4 (2 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a pregnancy high risk clinical trial?
Eligibility criteria for pregnancy high risk trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 4
2
Top Sponsors
IRCCS San Raffaele 2 trials
Ohio State University 2 trials
University of Massachusetts, Worcester 1 trial

Recruiting Clinical Trials

NCT05786235
Recruiting
Patients Pregnant Women With or Without Primary Antiphospholipid Antibody Syndrome
Enrollment
60 pts
Location
Italy
Sponsor
IRCCS San Raffaele
View Trial →
NCT05317585
Recruiting
Continuous Glucose Monitor Use in Pregnancy
Enrollment
180 pts
Location
United States
Sponsor
University of Massachusetts, W...
View Trial →
NCT07293715 Phase 4
Recruiting
Permissive Versus Strict Intrapartum Glucose Management in Type 1 and Type 2 Diabetes (PRISM)
Enrollment
44 pts
Location
United States
Sponsor
Ohio State University
View Trial →
NCT05807256
Recruiting
Medically Assisted Fertilization Techniques in Systemic Immunoreumatologic Diseases
Enrollment
500 pts
Location
Italy
Sponsor
IRCCS San Raffaele
View Trial →
NCT06445946 Phase 4
Recruiting
DECIDE: A Comparative Effectiveness Trial of Metformin Versus Insulin for the Treatment of Gestational Diabetes
Enrollment
1,572 pts
Location
United States
Sponsor
Ohio State University
View Trial →

Related Conditions

immunologic disease (2) pregnancy complications (2) rheumatic diseases (2) preeclampsia (1) antiphospholipid antibody syndrome primary (1) type 2 diabetes treated with insulin (1) type 1 diabetes (1) type 2 diabetes (1) fertility disorders (1) gestational diabetes mellitus (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology